Latest database descriptions

In HIV-1 positive patients who have been asymptomatic for at least 5 years after HIV infection in the absence of antiretroviral therapy, whether they meet the definitions of Long time non-Progressors and/or HIV Controllers and in patients on antiretroviral therapy and in "control after discontinuation of antiretroviral therapy", study their clinical and immuno-virological course and define the virus and host parameters associated with non-progression of infection.

To describe the treatment of strokes (practices, time periods, patient orientation, etc.) prior to hospitalisation, during hospitalisation and in the post-hospital phase in the Aquitainian health institutions
To describe the patient population treated for a stroke in sociodemographic and clinical terms.
To ensure monitoring of this patient population in terms of: the occurrence of complications during the stay, cardioneurovascular morbidity-mortality after 1 year, disability after 1 year

To determine the epidemiology, patient & tumour characterstics, biomarkers, detailed treatment patterns, safety, and clinical outcomes across 25+ solid and non-solid tumours in France, Germany, Italy, Spain and the UK.

Objectives: The main aims of this study are to assess the impact of structural factors (e.g. attendance at CAARUD [Reduction Support Centres for Drug Users] and CSAPA [Specialised Addiction Treatment Support and Prevention Centres]; prison; other environmental factors) and individual traits (personal history; sociodemographic factors; substance use; addictive disorder; other comorbidities) on trends in drug use, practices and treatment path; drug-user social circumstances, experience of violence and drug-related offences. Secondary aims involve drawing a map of the socio-behavioural situation of drug users; estimating the prevalence of specific drug use within the sample and to better understand the needs of drug users for treating addiction and also for screening and the management of disorders associated with drug use.